Created in 2015 (United States), DROPLESS CATARACT THERAPY own 6 sister brands. DROPLESS CATARACT THERAPY is owned by IMPRIMIS PHARMACEU COM USD0.001, listed on the stock exchange of New York DROPLESS CATARACT THERAPY belongs to the Divers business sector.
Share price and profitability of the share IMPRIMIS PHARMACEU COM USD0.001 (DROPLESS CATARACT THERAPY)
Buy IMPRIMIS PHARMACEU COM USD0.001 share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history IMPRIMIS PHARMACEU COM USD0.001 (DROPLESS CATARACT THERAPY)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
